Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

Incorporating mpMRI into initial staging before TURBT reduces the time to correct treatment for patients with MIBC.

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge ...

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the ...

Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr ...

Discover a study where findings demonstrated that the novel drug-injectable urethral catheter set increased patient ...

Using multiparametric MRI in place of TURBT in the initial staging of new bladder cancers can expedite treatment of ...

Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Usual tests for muscle invasive bladder cancer involve transurethral resection, which is a surgical procedure carried out under anaesthetic by a surgeon in which a thin telescope inserted through ...

The study saw 143 patients with suspected bladder cancer randomized into two groups, either going through the usual test called transurethral resection of bladder tumor (TURBT), or an initial MRI ...

Objective: To investigate the optimal cut-off value of immunohistochemical marker Ki67 as a prognostic factor to predict the recurrence of non-muscle invasive bladder urothelial carcinoma (NMIBUC).